How much funding has Telix Pharmaceuticals Limited raised?

Telix Pharmaceuticals Limited has raised $193.6M in total funding, most recently a Grant round.

Who are Telix Pharmaceuticals Limited's investors?

Telix Pharmaceuticals Limited's investors include Fidelity International.

When was Telix Pharmaceuticals Limited founded?

Telix Pharmaceuticals Limited was founded in 2015.

Where is Telix Pharmaceuticals Limited headquartered?

Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia.

What industry is Telix Pharmaceuticals Limited in?

Telix Pharmaceuticals Limited operates in Biotech, Healthcare.

How many employees does Telix Pharmaceuticals Limited have?

Telix Pharmaceuticals Limited has 201-500 employees.

Telix Pharmaceuticals Limited

IPO

Our mission is to help patients with cancer live longer with better quality lives | Telix Pharmaceuticals

Public · Melbourne, Australia · Founded 2015 · $193.6M raised

Biotech

Healthcare

Headquarters: Melbourne
Employees: 201–500
Founded: 2015
Business Model: B2B
Website: telixpharma.com

Total Funding: $193.6M
Last Round: $23.0M GrantJan 2022
Rounds: 3
Type: Public

About

Telix Pharmaceuticals is a commercial-stage biopharmaceutical company developing precision radiopharmaceuticals for cancer diagnostics and therapy (theranostics). Its pipeline targets urologic, neurologic, and musculoskeletal cancers using radioactive isotopes attached to targeting agents. Commercial products include Illuccix® (PSMA-PET/CT imaging). Headquartered in Melbourne with operations in the US, Belgium, Switzerland, and Japan.

Summary

Telix Pharmaceuticals Limited is a Biotech company based in Melbourne, Australia, founded in 2015. It has raised $193.6M in total across 3 rounds, most recently a $23.0M Grant round in Jan 2022. Investors include Fidelity International.

LinkedIn X (Twitter)